Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients.
暂无分享,去创建一个
J. Sonke | J. Belderbos | M. Kwint | J. Knegjens | I. Walraven | B. Stam | A. D. de Langen | J. V. van Diessen | A. D. de Langen